ABDM or others - With the directors selling some shares that opens a question or 2 for me :
There are so many unknown details to investors/potential new investors surrounding the P&G deal
What are the products?
What are the terms?
What is the first product license for and what are the royalties and what is the market sales for this product?
They as Directors know this information and they are selling.
I dont mind as an investor/potential investor understanding confidentiality and especially in the Biotech space that you have to be willing not to know the finer details - But the directors do know the finer details and they are choosing to sell.
Will continue to watch and thanks ABDM for all your research
- Forums
- ASX - By Stock
- WFL
- appendix 3y - christopher quirk
appendix 3y - christopher quirk, page-110
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
KAI
Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
Add WFL (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable